About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Now App may Help Opioid Overdose Victims With Lifesaving Rescue Drug

by Bidita Debnath on September 20, 2016 at 8:55 PM
Font : A-A+

 Now App may Help Opioid Overdose Victims With Lifesaving Rescue Drug

The Food and Drug Administration challenged computer programmers, public health advocates, clinical researchers and entrepreneurs to create an application that can connect opioid users and their friends and loved ones to someone nearby who has a dose of the prescription drug naloxone.

Naloxone quickly reverses the effects of an opioid drug overdose by plugging up the receptors in the brain to which opioid narcotics bind themselves. Now carried by emergency medical crews and available by prescription, naloxone can pull an opioid drug user out of a death spiral in minutes if it is administered quickly enough.

Advertisement


The FDA is deliberating over whether and how it can make naloxone available without a prescription. In the meantime, however, the reversal agent is in too few hands to save all who might benefit.

That's where a well-designed mobile app might help. If an opioid drug user is found unresponsive with a weak pulse and shallow breathing, the person first on the scene might turn to a naloxone finder on her cellphone to get a dose quickly.
Advertisement

Associate FDA Commissioner Peter Lurie suggested that in a large apartment building, for instance, a first responder might find a neighbor just down the hall who has a dose of naloxone in the medicine chest. "There's not a minute to waste," Lurie said, and an app that could speed the arrival of naloxone could save lives.

Lurie acknowledged there probably are legal issues to be worked out, including laws or legal waivers that would absolve a provider of naloxone of liability in the event his or her rescue does doesn't work or prompts an adverse reaction. Those might be modeled on "good Samaritan" laws, adopted by many states, which exempt from liability anyone providing cardiopulmonary resuscitation to someone who appears to have had a heart attack.

More difficult might be the challenge of getting drug users to download an app that speeds the arrival of a reversal drug many are loathe to use. Naloxone's rapid reversal action also brings a drug user's high to an abrupt end. Even when drug users' breathing and heartbeat have nearly stopped, they are rarely aware of their peril and rarely grateful for the rescue.

To get app designers going on their submissions, the FDA will host a "code-a-thon" on Oct. 19 and 20. Final submissions are due to the agency by Nov. 7.

The submissions will be assessed for innovation, usability, functionality and adaptability by a panel of judges from the FDA, the National Institute of Drug Abuse and the Substance Abuse and Mental Health Services Administration. The highest-scoring entrant will receive an award of $40,000. And all entrants may apply for Small Business Innovation Research grants from the National Institute of Drug Abuse after the competition is over.

The contest was launched under a 2010 law that allows federal agencies to conduct prize competitions to spur innovation and solve tough problems. This is only the second time the FDA has held a prize competition to help solve a pressing public health need. In the first, the winning entrant developed a means of rapidly identifying salmonella bacteria in fresh produce a technology FDA field labs across the nation have begun to use.

Source: Medindia
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Drug News

 Combination Therapy Benefits Septic Shock Patients
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Now App may Help Opioid Overdose Victims With Lifesaving Rescue Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests